Richard Turnbull's Professional Contact Details

+43 720 554215
Ely, England

Richard Turnbull's Current Company Details

F-star is a biopharmaceutical company dedicated to developing novel bispecific antibody products that provide a significant improvement over the current standard of care. Given its strong patent position, it is...
F-star is a biopharmaceutical company dedicated to developing novel bispecific antibody products that provide a significant improvement over the current standard of care. Given its strong patent position, it is the only biopharmaceutical company with the ability to create and develop Fcab:tm: antibody fragments, and bispecific antibodies, by modifying the constant region of an antibody. In particular, F-star’s Modular Antibody Technology:tm: enables rapid discovery and development of bispecific antibodies by introducing additional binding sites to the constant region of an antibody and offers unprecedented ease in the development and manufacturing of bispecific monoclonal antibodies. Using the Modular Antibody Technology, F-star generates bispecific antibodies (mAb2:tm:) that possess the favourable characteristics of traditional monoclonal antibodies, without the production challenges often associated with other antibody formats. F-star is now applying its proprietary technology to the development of a pipeline of product candidates. Since its founding in 2006 the company has secured funding and support from leading VC investors: Aescap Venture, Atlas Venture, Novo Ventures and TVM Capital; as well as from renowned strategic corporate investors: Merck Serono Ventures, MP Healthcare Venture Management and SR One. In 2013, F-star established an asset-centric vehicle structure through the formation of F-star Alpha Ltd., which included out-licensing of FS102 from F-star to F-star Alpha Ltd. In October 2014 Bristol-Myers Squibb obtained an exclusive option to buy F-star Alpha. In addition the company has alliances with Boehringer Ingelheim and Merck Serono, each covering multiple targets. In 2011, F-star was selected by FierceBiotech as one of the Fierce 15 winners. F-star currently employs over 35 people at its research site in Cambridge, UK.
bispecific antibodies
phage display
life sciences
biotechnology: pharmaceutical preparations
health care
medical research & laboratories
health, wellness & fitness

Richard Turnbull's Work History and Education

F-star Therapeutics, Inc.
IT Systems Engineer
2020 - Present
G's Group
2nd Line Support Engineer
2005 - 2020 • 14 years

Others Named Richard Turnbull

Marketing and Communications Manager at UNW LLP
Environmental Health Officer at Queensland Health
Currently Non Executive Director Newcastle Anglican Church Corporation at Anglican Diocese of Newcastle
Sales and Product Specialist at Stewart Travel Group
Application Consultant at Schoolworks Ltd

Frequently Asked Questions about Richard Turnbull

What company does Richard Turnbull work for?

Richard Turnbull works for F-star Therapeutics, Inc..

What is Richard Turnbull's role at F-star Therapeutics, Inc.?

Richard Turnbull's role at F-star Therapeutics, Inc. is IT Systems Engineer.

What is Richard Turnbull's email address?

Richard Turnbull's email address is r**

What is Richard Turnbull's business email address?

Richard Turnbull's business email address is r**

What is Richard Turnbull's HQ phone number?

Richard Turnbull's HQ phone number is +43 720 554215.

What industry does Richard Turnbull work in?

Richard Turnbull works in the Biotechnology industry.

Who are Richard Turnbull's colleagues?

Richard Turnbull's colleagues are David Arkowitz, Francisca Wollerton, Ioannis Diamantopoulos, Jennifer Ofoedu and more.
CFO and Head of Business Development
Senior Director Antibody Engineering
Research Associate
Chief Medical Officer

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

"We love the interface, the experience, and most importantly… the results."

Erik Straub

Chief Marketing Officer, Kickfurther

"Using Apollo, we’ve solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects."

Michael Transon

CEO, Victorious

Ready to try it out?

Get started for free, then add your whole team. You can always talk to sales if you’re interested in advanced plans.